Background
The ideal goal is to maintain the natural dentition in health, comfort, and function while preserving or enhancing the patient's esthetic appearance. Historically, regenerative treatment for periodontal intrabony lesions has focused on the use of monotherapies [1] [2] [3] [4] to restore the lost hard tissues: bone, cementum, and a functional periodontal ligament. Combination regenerative approaches have been quite successful for treating the more challenging intrabony lesions, particularly as the size and complexity of the lesion increases. [5] [6] [7] Typically, these efforts have included a bone replacement graft that has been covered by an exclusionary barrier. Although this approach to regeneration has been quite successful, there still remains a concern that the graft material may act strictly as a space filler and not have the intrinsic biologic capability to provide for regeneration. 8 Furthermore, when the graft may be inductive, its regenerative capacity could still be limited by its ability to maintain space or to be contained. 9 More recently, biologics have been introduced to enhance wound healing and recruit the appropriate cells needed for periodontal regeneration. [10] [11] [12] Although the results in a clinical trial 13 and case reports 14, 15 have been encouraging, situations present themselves that require additional care, such as restoring soft-tissue recession on a maxillary anterior tooth. The subepithelial connective tissue graft has been the gold standard in providing for successful root coverage [16] [17] [18] and, if it were to be combined with a bone graftÀbiologic in one surgery, perhaps both problems could be corrected. This case report provides preliminary evidence that the use of a layered reconstructive approach can be successful in addressing both the hard-and soft-tissue problems on a maxillary canine with an intrabony defect and a concurrent mucogingival deformity.
Treatment
The patient was a 70-year-old white female. Medical history included osteoporosis for which calcium was taken, prosthetic knee replacement, and mitral valve prolapse, the latter of which required 81 mg acetylsalicylic acid and clopidogrel. Her chief concern was the recession and root sensitivity present on her maxillary right canine ( Fig. 1 ), although she still had residual pocketing elsewhere in her mouth after the completion of scaling and root planing in her initial therapy. Furthermore, a periapical radiograph revealed an intrabony lesion at the distal aspect of this tooth (Fig. 2 ) that had 3 mm of direct facial recession and a probing depth (PD) of 7 mm at its distofacial. Furthermore, the patient reported no previous periodontal surgical care for this lesion. Occlusal evaluation revealed a congenitally missing lateral incisor. Group function was noted in working movement with no fremitus. Mobility was 0 8 for all teeth in the quadrant. Before treatment, her oral hygiene efforts were reviewed and reinforced, and it was determined to treat this area first with a regenerative surgical approach.
The patient rinsed immediately before the surgery with a 0.12% chlorhexidine mouthwash and was premedicated with 2 g amoxicillin 1 hour before surgery. Anesthesia was obtained using local infiltration with 4% articaine with 1:100,000 epinephrine. A sulcular incision with coronal full thickness and apical partial thickness flap was elevated on the buccal from tooth #4 to tooth #8 with preservation of papillae at the interproximal between teeth #5 and #6, the site of the intrabony lesion. The papilla was elevated to the palate. Reflection revealed a three-wall intrabony lesion at the distal aspect of the canine. The defect was thoroughly debrided, and the roots were scaled and planed with ultrasonic and hand instruments (Fig. 3 ). This preparation of the roots attempted to both remove the outer affected surface and flatten the root to facilitate its coverage. A tetracycline solution was applied to the root of tooth #6 for additional debridement using moistened cotton pellets to vigorously burnish this area for 2 minutes. This solution was formulated by dissolving a 250 mg capsule into 5 mL sterile water. The tetracycline solution was rinsed from the root, and intramarrow penetration was performed in the lesion to enhance the blood supply to the site. Immediately afterward, a purified recombinant protein of platelet-derived growth factor-BB (PDGF-BB) ‡ was applied to the conditioned root through a cannula tip while carefully isolating the site to avoid any contamination from either blood or saliva. Before this root preparation, a mineralized freeze-dried bone allograft (FDBA) x was reconstituted with PDGF-BB by adding enough of the purified solution to minimally wet the graft particles. This graftÀbiologic was placed in the lesion with light incremental pressure to fill or slightly overfill it (Fig. 4) . A chorionÀamnion barrier { was placed over the FDBAÀ PDGF-BB to contain it should there be any postsurgical flap dieback and to prevent any gingival connective tissue from entering into it (Fig. 5) . A subepithelial connective tissue graft was harvested from the right palate in the region of the premolar teeth using the technique described by Bruno. 19 PDGF-BB was applied immediately to the graft after its removal from the donor site, and it was immediately secured at the recipient site with 6-0 chromic gut using an interrupted suturing technique (Fig. 6 ). The connective tissue graft was placed up the cemento-enamel junction in hope of complete root coverage. The flap was coronally positioned to cover the connective tissue graft in its entirety and was secured with a monofilament 7-0 polytetrafluoroethylene suture using an interrupted technique (Fig. 7) . Care was taken to ensure that the flap was passively held over the treated site.
Infection control consisted of prescribing 875 mg amoxicillin to be taken twice daily for the first 7 days. For analgesia, acetaminophen with codeine #3 was taken as needed every 4 to 6 hours. The patient was seen approximately every 14 days for postoperative treatment during the first month. Sutures were removed at the first visit (Fig. 8) . She was then seen every other week for months 2, 3, and 4 and then at 6 months after surgery. Postoperative visits included plaque debridement, polishing to remove stains, and oral hygiene reinforcement. Chlorhexidine at 0.12% was topically applied with a cotton swab to the site by the patient for postoperative plaque management for the first 30 days when she refrained from both brushing and flossing to provide wound quiescence. After the first 30 days, mechanical oral hygiene was reinstated, and the patient began rinsing with an essential oil mouthrinse twice daily. At 6 months, an updated radiograph was exposed, suggesting favorable improvement in hard tissue (Fig. 9) , and the clinical parameters mirrored this favorable outcome FIGURE 4 After root planing, tetracycline root modification, and application of PDGF-BB to the root, an FDBA that was reconstituted with PDGF-BB was placed into the defect. 
FIGURE 6
A connective tissue graft that was harvested from the right palate was secured over the root with 6-0 chromic gut using an interrupted suturing technique.
FIGURE 7
The flap was secured over the site with 7-0 expanded polytetrafluoroethylene again using an interrupted suturing technique. The flap was coronally advanced to cover over the connective tissue graft.
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with complete root coverage, shallow PDs of 2 to 3 mm, and a gain in clinical attachment level of better than 50% (Figs.  10 and 11 ).
Discussion
The ability to maintain periodontally diseased teeth with regenerative efforts is now more predictable than ever as a result of refined techniques, biologic agents, and scaffolds that are at our disposal. Today, the question should not be how soon should we be removing a tooth with periodontal disease, but rather how early should regenerative care be applied when we see intraosseous lesions.
The use of a biologic agent such as PDGF-BB when combined with a bone graft has provided clinical regenerative outcomes that are quite favorable. 14, 15 Placing a barrier material over the graftÀbiologic composite was performed to reduce the likelihood of exposure to the oral environment during the period of postoperative wound healing. For this patient, a chorionÀamnion barrier was selected to not only contain the graft but to also prevent the ingrowth of connective tissue into the future developing attachment apparatus. The advantages of this particular barrier are that it is extremely thin, measuring 300 mm after full hydration, with the major non-collagenous components being laminins, proteoglycans, and fibronectin, further enhancing its tissuefriendly nature. 20, 21 Considering that the lesion was located at the interproximal region, dieback of the papilla could have been a real possibility, exposing the graft material to the oral environment and diminishing its efficacy.
The need for treating the facial recession related to both the patient's concern with the poor esthetic appearance and experiencing tooth sensitivity. Although the use of coronal flap advancement may have provided a solution for this problem, the thin nature of the gingiva may have been suboptimal to both achieve and maintain this goal. 22 The subepithelial connective tissue graft has been a very predictable method for achieving root coverage, and it is the standard to which other techniques are compared. 23, 24 Case reports have demonstrated regeneration in humans after the use of a subepithelial connective tissue graft. 17, 25 An added benefit, if procured with an intact periosteum, might be its ability to serve as an exclusionary barrier/graft containment device. 26, 27 The use of the PDGF-BB may have further enhanced the viability of the connective tissue because this agent promotes angiogenesis, complementing the actions of vascular endothelial growth factor in vessel formation. 28 
FIGURE 10
Clinical view at 6 months shows the successful repair of the mucogingival deformity with complete root coverage. Although this combined regenerative approach obtained a very favorable clinical outcome in this one case, it is important to remember that success is still strongly related to adequate root debridement and stringent follow-up maintenance care. 29 Additional case series and randomized controlled trials need to be performed on a much larger scale with more challenging vertical bony and soft-tissue defects to determine the efficacy of this approach over a larger number of patients.
Conclusions
This case report, in which a combined approach that included a mineralized bone allograft, recombinant PDGF, and a chorionÀamnion barrier covered by a subepithelial connective tissue graft, was successful for correcting both the hard-and soft-tissue deformities around a maxillary canine. Additional prospective controlled studies are needed to determine how this compares to other methods more traditionally used. n Summary Why is this case new information?
n Combines soft-and hard-tissue regenerative procedures to treat a mucogingival deformity and intrabony defect simultaneously n Layers four types of care: 1) use of a biologic (recombinant PDGF); 2) a bone replacement graft; 3) a chorionÀamnion barrier; and 4) a subepithelial connective tissue graft
What are the keys to successful management of this case?
n Proper diagnosis and treatment planning n Preoperative occlusal management n Thorough root preparation n Graft containment/clot stabilization n Strict adherence to maintenance
What are the primary limitations to success in this case?
n Poor handling of soft tissues n Inadequate root preparation n Strict adherence to postoperative maintenance care, particularly during the earlier stages of healing
